登录 | 注册    关注公众号  
微信公众号
搜索
 > 【B7-H3】

B7-H3信息

英文名称:CD276 antigen
中文名称:CD276抗原
靶点别称:B7 homolog 3,PSEC0249,UNQ309/PRO352,B7-H3,CD276 antigen,B7H3,CD276,CD276 Molecule,Costimulatory Molecule,4Ig-B7-H3,B7RP-2
上市药物数量:0
临床药物数量:39
最高研发阶段:申请上市

抗体项目交易平台

项目名称 项目阶段 分子类型 分子来源 疾病领域 适应症
B7H3 mAb - 01 PCC 单抗 鼠源人源化 实体瘤 肺癌

Licensing 项目合作

项目名称 药物类型 治疗领域 适应症 阶段 权益地区
B7H3×PD-L1双特异性抗体 双抗,多抗 肿瘤学,癌症 B7H3 + 和PD-L1 +/low的肿瘤,例如脑胶质瘤及前列腺癌 临床前 全球
Anti-B7H3 ADC治疗泛癌种 生物偶联药物 肿瘤学,癌症 泛癌种 PCC 全球
B7-H3×CD3 BsAb治疗晚期实体瘤 双抗,多抗 肿瘤学,癌症 实体瘤 临床前 全球

B7-H3分子别名

B7-H3,CD276,B7 homolog 3

B7-H3分子背景

B7 homolog 3 (B7-H3), a member of the immunoglobulin superfamily, is also known CD276, which contains two Ig-like C2-type (immunoglobulin-like) domains and two Ig-like V-type (immunoglobulin-like) domains. B7-H3 may participate in the regulation of T-cell-mediated immune response. B7-H3 also plays a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. Furthermore, B7-H3 is involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. It could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy.

B7-H3临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定